Sanjit S. Jolly and Dr. C Michael Gibson Discuss: CLEAR SYNERGY (OASIS 9)A 2×2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction: The Results of the Colchicine Factorial October 29, 2024 Disclosures: TBD
Dr. David Schnieder and I discuss a new cardiovascular risk marker: Platelet pFCG October 24, 2024 Disclosures: TBD
Dr. Jacob Eifer Møller Presents: Percutaneous Transvalvular Micro-axial Flow Pump In Infarct Related Cardiogenic Shock. Results Of The Danger-shock Trial Slides April 11, 2024 Disclosures: TBD
Dr. Michael Nanna and Dr. Gibson discuss the PRECISE trial. February 14, 2024 Disclosures: s/b HeartFlow
Dr. Harlan Krumholz shares vision for the Journal as the new Editor-in-Chief of JACC December 8, 2023
Dr. Manesh Patel and Dr. C. Michael Gibson Discuss: The early termination of the OCEANIC AF study of the Factor Xi Inhibitor Asundexian due to lack of efficacy November 30, 2023
Dr. Demilade A Adedinsewo Presents: Screening for Peripartum Cardiomyopathies Using an Artificial Intelligence Enhanced Digital Stethoscope: A Randomized Clinical Trial November 15, 2023 Disclosures: TBD
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: CLEAR OUTCOMES subanalysis on predicting CV events November 13, 2023 Disclosures: TBD
Dr. Richard Wright and Dr. C. Michael Gibson Discuss: The Genetic / Mendalian randomization (natures randomized trial) data that supports the efficacy of Acoramadis in amyloidosis and the potential for amyloid regression with therapy November 13, 2023 Disclosures: TBD
Dr. Charalambos Antoniades and Dr. C. Michael Gibson Discuss: Novel AI Technology to Improve Risk Stratification of Patients Without Obstructive Coronary Artery Disease Undergoing CCTA: The Oxford Risk Factors and Non-Invasive Imaging (ORFAN) Study November 13, 2023 Disclosures: TBD
